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Background: Severe adverse reactions (SARs) associated with physical exercise have not been systematically studied in cystic fibrosis (CF).
Methods: Two surveys were conducted to assess the incidence of exercise-related SARs: a caregiver survey asking for complications associated
with exercise testing and in-hospital training therapy and a web-based patient survey asking for problems with exercise.
Results: 78 of 107 CF facilities caring for 4208 patients responded to the caregiver survey, 256 patients answered the web-based survey. No SARswere
reported for 713 exercise tests.With in-hospital training, the yearly incidence of exercise-related SARs such as pneumothorax, cardiac arrhythmia, injury
or hypoglycaemia was b1% each, the respective lifetime incidences reported by the patients were 0.8–6.3%. 67% of the patients reported no SARswith
exercise.
Conclusions: Exercise testing is safe in patients with CF. Despite the limitations in quality of data, the incidence of exercise-related SARs appears
low in this population.
© 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic fibrosis; Exercise testing; Physical activity; Risks; Adverse reactions1. Background
Physical activity has become an important component in the
treatment of patients suffering from cystic fibrosis (CF). Several
studies have shown that these patients benefit from physical
exertion in many respects: a higher physical fitness, a slower
decline in lung function, and a higher quality of life [1]. As regular
exercise seems to be an enjoyable, simple and cheap way to affect
the clinical course of CF, patients are encouraged to engage in
exercise [2,3]. It has to be kept in mind, however, that CF is an
illness that causes pathological changes of pulmonary and cardiac
function and may negatively affect the endocrine and musculo-
skeletal system (as in CF-related diabetes and osteoporosis) and
that therefore exercise might bear certain risks.
Exercise-induced oxygen desaturation has been studied in
the past and can easily be assessed and treated [4,5]. Little is⁎ Corresponding author. Universitäts-Kinderklinik, Josef-Schneider-Str. 2,
97080 Würzburg, Germany. Tel.: +49 931 201 27101; fax: +49 931 201 27242.
E-mail address: ruf_k@klinik.uni-wuerzburg.de (K. Ruf).
1569-1993/$ - see front matter © 2010 European Cystic Fibrosis Society. Publishe
doi:10.1016/j.jcf.2010.05.006known, though, about other severe health hazards associated
with exercise in CF such as pneumothorax, cardiac arrhythmias,
hypoglycaemia, and fractures as such adverse reactions to
exercise have been underexamined so far.
Hence, the aim of this study was to identify adverse reactions
associated with exercise in CF and their incidence. Ques-
tionnaires addressing caregivers and patients were employed to
include a large sample.
In this study, the term ‘exercise’ is used to describe physical
activities as well as sports, as we consider it to summarize best
the items asked for in the questionnaires. Furthermore, the term
exercise is widely used when referring to any kind of physical
activity recommended to patients with CF [2,6–8].2. Materials and methods
This study comprises two independent studies, in which
adverse reactions to exercise were assessed with the help of ques-
tionnaires. In the first study that took place in 2005, caregivers ofd by Elsevier B.V. All rights reserved.
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reactions to exercise that had occurred during 2005. A second
questionnaire that addressed the patients directly was administered
in 2008. Both questionnaires were translated into English and are
available as appendices.
The first survey addressing the caregivers took place
between April and December 2006. With the help of the
German CF foundation (“Mukoviszidose e.V.”), a three-page
questionnaire was sent via mail to all German institutions caring
for patients with CF, namely 101 German CF centres (university
hospitals, non-academic hospitals, and private offices) and to 6
rehabilitation hospitals specialised in the treatment of CF.
From the 107 CF care facilities contacted we obtained
answers from 78 facilities (among these 6 rehabilitation
hospitals). If caregivers did not respond to the questionnaire,
we contacted them via the “Mukoviszidose e.V.” twomore times
and sent the questionnaire again to enhance the return rate, which
finally was 73%. The facilities responding reported data of 4208
patients. 3774 of these patients were seen in CF centres. This
sample represents 83% of all patients recorded in the German CF
registry for 2005 [9]. 434 patients were treated as in-patients in
rehabilitation institutions. Further information regarding
patient's height, weight, and exercise testing data was not
included in the survey as the focus lay on capturing adverse
reactions.
Whereas the caregiver survey mainly focused on adverse
reactions during in-hospital exercise, the second survey
addressed the patients directly and asked for adverse reactions
related to non-supervised exercise at home. This second,
anonymous survey addressed patients using a web-based
approach and took place in 2008. All German patients with CF
were invited to participate by their CF centre, by regional patient
groups, and through an announcement in the German CF
magazine. Patients were invited no matter whether their
institution had taken part in the 2006 caregiver survey or not.
Thus, this descriptive study used a convenience sample of
patients from Germany whose data are most likely also included
in the German CF registry.
The ethics committee of the University Hospital of
Würzburg approved this survey which was published on the
website http://www.mukosport.info. Informed consent wasTable 1
Incidence of exercise-associated adverse reactions in the caregiver survey (2005).
Exercise testing (n=434 in 29 CF care centres plus n=279 in 5 rehabilitation institutio
In-hospital physical training therapy (n=557 in 31 CF centres plus n=338 in 6 rehabili
hospitals)
Note: the percentages given were calculated by dividing the number of respective ad
the number of patients participating in in-hospital physical training therapy, respectobtained through ticking consent boxes on the first page of
the questionnaire. Participants or their legal guardians con-
sented that they accepted the privacy statement explained on the
website; furthermore they agreed to their data being saved and
to the analysis of their data for scientific purposes.2.1. Questionnaires
Both questionnaires employed were developed by KR and
HH to specifically assess severe adverse reactions to exercise in
patients with CF. For the list of possible adverse reactions, we
considered reactions encountered in our own clinical experience
[5,10] and from anecdotal reports of other CF clinicians. We
selected only adverse reactions which were considered severe
and thus clinically relevant. Reliability and validity of the
questionnaires were not established. However, we assume that
severe adverse reactions would be remembered well.
The caregiver questionnaire assessed complications during
exercise testing and in-hospital physical training therapy which
had occurred in 2005 in the respective institutions. Specifically,
we asked for cardiac arrhythmia, pneumothorax, and hypogly-
caemia during exercise testing and these three adverse reactions
plus injuries (strains, contusions, and fractures) during in-
hospital physical training therapy. Each institution returned
only one questionnaire, which summarized all adverse reactions
that had occurred in the respective institution.
The patient questionnaire asked the patient or his or her
guardian for actual age, height, weight, FEV1 (in % predicted),
and colonization with Pseudomonas aeruginosa. Furthermore,
the questionnaire asked for the following adverse reactions to
exercise which might have occurred anytime in the patient's past:
pneumothorax, injuries, loss of consciousness, and asthma attacks
(acute dyspnoea and cough occuring after the end of the exercise)
associated with exercise. These questions were worded as closed
questions, i.e. patients chose one or more statements out of a list
provided. Patients, though, had extra space to specify their
adverse reactions and to give additional comments. There was
also space to add further severe adverse reactions. Reactions that
were additionally reported were hypoglycemia, haemoptoe and
arthritis manifesting or significantly worsening during exercise.Adverse reaction Number of reported patients for 2005
(% of respective sample)
ns Cardiac arrhythmias 0
Pneumothorax 0
Hypoglycemia 0
tation Cardiac arrhythmias 1 (0.1%)
Pneumothorax 0
Hypoglycemia 4 (0.4%)
Injuries such as fractures, strains,
contusions
8 (0.9%)
verse reactions by the total number of patients undergoing exercise testing or by
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Data are presented descriptively as number of reported
adverse reactions separately for exercise testing, in-hospital
physical training therapy (both taken from the caregiver survey)
and lifetime complications of exercise reported by the patients.
In the patient survey, group differences between patients with
adverse reactions and those without adverse reactions were
tested. A Chi-Square test was used to test for differences
between male and female patients with regard to the incidence of
the various adverse reactions assessed (injury, pneumothorax,
asthma attack, haemoptoe and arthritis manifesting during
exercise). Mann–Whitney-U-Tests (due to a lack of normal
distribution identified with the help of the Kolmogorov–
Smirnov test) were used to assess differences between patients
with and without an adverse reaction (injury, pneumothorax,
asthma attack, haemoptoe and arthritis manifesting during
exercise) with regard to age, weight, and FEV1%. Incidence
rates relative to the number of exposed patients and – for the data
from the patient survey only – relative to 1000 patient years were
also calculated.
Data of the online survey was retrieved from the online
platform as excel file (Excel, Microsoft); all statistical analysis
were performed by SPSS 16.0 (SPSS Inc.).
3. Results
3.1. Caregiver survey
Questionnaires were returned by 72 non-rehabilitation CF
centres and 6 rehabilitation centres. In the group of the non-
rehabilitation CF centres, exercise testing was performed by 29
institutions (40%). All in all, 434 patients (10%) were tested
(213 adults older than 18 years and 221 children). An in-patient
physical training therapy was part of the treatment in 31 CF
centres (43%), with 557 patients attending the programs, among
these 319 adults and 238 children. In the group of the
rehabilitation hospitals, 5 of 6 institutions performed exercise
testing and tested 279 (64%) of the 434 patients seen in these
hospitals, 104 adults and 175 children. All rehabilitation
hospitals offered in-patient physical training therapy; 338
patients (78%) participated in respective programs, 101 adults
and 237 children.
During exercise testing, no adverse reactions occurred. The
incidence of adverse reactions during in-patient physical training
therapy was below 1% for each of the assessed complications
pneumothorax, hypoglycaemia, injury, and cardiac arrhythmias
(Table 1).
3.2. Patient survey
In total, data from 256 patients (146 females) aged 0 to
65 years (mean age 26 years), with an FEV1 between 10 and
125% predicted (on average 68%) and a mean reported
engagement in exercise of 3.6 hours per week became available.
Among the 256 patients (representing 5% of the patients
reported to in the German CF registry in the year 2008), 46 (18%
Table 3
Participants' engagement in different activities reported in the patient survey
(2008).
Activity Number of participants'
replies (n=403)
% of all participants'
replies (n=403)
Endurance activities (e.g.
running, cycling,
swimming, and walking)
166 41.2
Team Sports (e.g. soccer,
volleyball, and handball)
51 12.6
Individual Sports (e.g. tennis,
yoga, gymnastics, dance,
martial arts, and rowing)
93 23.1
Fitness centre/weight training 93 23.1
Note: Patients had the possibility to report more than one activity. In order to create
the table, the patients' answers were clustered into the above four categories. Some
patients mentioned more than one activity within a category. In order to create the
percentages, these multiple activities within a category were seen as one only.
In total, 46 patients (18% of all patients included in the survey) did not report
any activities.
342 K. Ruf et al. / Journal of Cystic Fibrosis 9 (2010) 339–345of the study sample) did not engage in any exercise. 168 patients
were chronically colonized with P. aeruginosa. The population
responding to the survey was thus on average somewhat older
than the average patient in the German registry (19.1 years in the
registry vs. 25.9 years in the survey) and had a slightly worse
lung function (FEV1: 72.4% in the registry vs. 67.8% in the
survey). In our experience, the reported sports participation is
relatively representative for German patients. Hebestreit et al.
[11] found an average time spent in vigorous physical activity ofTable 4
Characteristics of patients with and without exercise-associated adverse reactions an
P. aeruginosa
colonization
Age (years)
Mean±SD [ran
Pneumothorax a Yes 7 (70%) 34.8 ± 18.9 [1
44]N=10
No 161 (68%) 25.6±11.2 [0–6
N=246
Injury a Yes 11 (69%) 26.8±9.0 [11–4
N=16
No 157 (65%) 25.9±11.4 [0–6
N=240
Asthma attack (acute shortness of breath
and cough occurring after exercise) b
Yes 43 (77%) 28.4±8.8 [11–4
N=56
No 125 (63%) 25.2±11.8 [0–
N=200
Arthritis manifesting during exercise b Yes 8 (89%) 30.3±11.1 [11–
N=9
No 160 (68%) 26.0±11.2 [0–6
N=247
Haemoptoe b Yes 7 (88%) 30.1 (7.2) [20-4
N=8
No 161 (68%) 25.8 (11.3) [0–6
N=248
Hypoglycemia b Yes 1 28, 31
N=2
Loss of consciousness a Yes 2 27, 31
N=2
a The survey asked specifically for these severe adverse reactions occurring durin
b These severe exerciserelated adverse reactions were additionally reported by the4.3 h per week in their study population. The patients'
characteristics of the web-based survey are presented in Table 2.
The engagement in the different activities reported by the
patients is summarized in Table 3. The activities reported have
been clustered into four categories: endurance, team sports,
individual sports, and fitness centre/weight training. In Table 3,
examples for each category are provided.
171 of the 256 responding patients (67%) had not encountered
any serious problem during exercise. The adverse reactions that
were reported by the patients are summarized in Table 4. In total,
85 patients reported adverse reactions associated with exercise.
Themost common adverse reactionwas an asthma attack (22% of
all patients in the survey), followed by injury (6%), pneumothorax
(4%), and loss of consciousness (1%). Adverse reactions not
specifically asked for in the survey but reported by the patients
were arthritis worsening with exercise (4%), haemoptoe (3%),
and hypoglycaemic events associated with exercise (1%).
Pseudomonas colonization and a low FEV1 were associated
with asthma attacks while high age was a risk factor for
pneumothorax (Tables 4 and 5). Female patients weremore likely
to report arthritis manifesting or worsening during exercise
(Tables 4 and 5).4. Discussion
As regular exercise is a recommended treatment for patients
with CF and increasingly established as an important compo-
nent of CF therapy, this study intended to gain an insight intoytime in life reported in the patient survey 2008.
ge]
Gender
m = male
f = female
FEV1 (%)
Mean±SD [range]
Weight (kg)
Mean±SD [range]
Incidence per
1000 patient years
8– 4 m, 6 f 61.9±23.3 54.2±15.4 0.15%
[21–93] [12–95]
5] 106 m, 140 f 68.2±24.8 56.5±10.4
[10–125] [44–77]
1] 6 m, 10 f 69.6±25.3 53.9±15.5 0.39%
[22–105] [12–95]
5] 104 m, 136f 67.8±24.8 59.4±9.5
[10–125] [41–77]
9] 22 m, 34 f 58.5±25.3 53.7±16.0 0.84%
[14–115] [12–95]
65] 88 m, 112f 70.4±24.1 56.4±11.9
[10–125] [16–82]
43] 1 m, 8 f 57.2±12.8 54.2±15.4 0.14%
[40–73] [12–95]
5] 109 m, 138f 68.3±25.0 55.9±10.7
[10–125] [34–73]
4] 4 m, 4 f 69.3±20.8 54.1±15.4 0.12%
[22–105] [12–95]
5] 106 m, 142f 69.0±24.9 61.3±4.8
[10–125] [53–37]
1 m, 1 f 72, 89 56, 69 0.03%
1 m, 1 f 70, 75 54, 77 0.03%
g or shortly after exercise.
patients.
Table 5
Risk factors for severe adverse reactions to exercise in patients with CF. The table shows probability (p)-values of a type 1 error when assuming a significant difference
between patients with and patients without a severe adverse reaction with respect to gender, P. aeruginosa colonization, age, FEV1, and weight based on Chi-Square-
and Mann–Whitney-U-test statistics.
Gender
p-value a
P. aeruginosa colonization
p-value a
Age (years)
p-value b
FEV1 (%)
p-value b
Weight (kg)
p-value b
Pneumothorax c 0.847 0.776 0.008 0.500 0.839
Injury c 0.648 0.186 0.767 0.640 0.143
Asthma attack c 0.529 0.047 0.067 0.002 0.221
Arthritis manifesting during exercise d 0.049 0.135 0.217 0.137 0.776
Haemoptoe d 0.683 0.186 0.246 0.966 0.079
Bold data are those p-values which are significant.
a Chi-Square-test.
b Mann–Whitney-U-test.
c The survey asked specifically for these severe adverse reactions occurring during or shortly after exercise.
d These severe exercise-related adverse reactions were additionally reported by the patients.
343K. Ruf et al. / Journal of Cystic Fibrosis 9 (2010) 339–345possible serious risks of exercise for CF patients. We tried to
cover a large number of patients in order to identify problems
with a low incidence.
The yearly incidence of cardiac arrhythmias during exercise
testing and in-patient physical conditioning in our caregiver
survey was 0–0.1% and matches that of the healthy population
[5,12,13] but appears far lower than recently reported for CF
patients [5]. This latter discrepancymay reflect an unawareness of
caregivers with respect to exercise-induced cardiac arrhythmias
resulting in less ECG recordings during exercise tests and thus a
low detection rate.
More than 10% of all patients with CF suffer from a CF-related
diabetes mellitus and even more from an impaired glucose
tolerance [14]. Although there are reports on hypoglycaemic
episodes in patients with CF [15] the role of exercise as trigger of
symptomatic hypoglycaemias has not been explored. We found
an incidence of exercise-induced symptomatic hypoglycaemia in
0.4% of all patients represented in our caregiver survey and 0.8%
in the patient survey. These numbers are low compared with the
20% incidence of hypoglycaemias with loss of consciousness
reported by patients with CF-related diabetes [16] even if the
prevalence of this condition among the CF population is assumed
to be only 10% and thus somewhat less than that reported for
German patients [14]. This may be due to a certain underreporting
in the web-based survey as we did not explicitly ask for
hypoglycemia but relied on the patients to mention it in the
additional space for further severe adverse reactions.
We found a lifetime incidence of pneumothoraces of about
4% in our patient survey. This is in line with Flume [17] who
reported an incidence of 3.4% spontaneous pneumothoraces in a
population of 965 patients with CF. The patients with
pneumothorax in our population had a FEV1 ranging from
21% to 93% predicted and older age but not FEV1 was the only
detectable risk factor. Five of the ten patients gave explanations
for the situations when the pneumothorax occurred. All 5
patients reported that the pneumothorax occurred after a period
of infection while coughing with exercise. Hence, at least 50%
of the pneumothoraces reported in our survey were associated
with cough, which may or may not have been exercise-induced.
Concerning exercise-related injuries, we found a yearly
incidence of 0.9% during a supervised in-hospital physicaltraining therapy and an overall lifetime incidence of 6.3% in the
patient survey. This seems extremely low in comparison to
epidemiological studies on sports injuries in children and
adolescence [18–20]. Based on the low incidence of injuries,
CF-related osteoporosis did not seem to cause exercise-related
fractures. A possible explanation for this low incidence is that
CF patients may participate in less injury-prone activities or
may exercise less vigorously than healthy people. Another
reason for the low incidences of reported injuries in our surveys
could be a recall bias, as minor injuries may not be remembered
well and might, thus, have been underreported.
The limitations of our study certainly are that both surveys
are subject to recall and participation bias. Minor adverse
reactions may not be recalled at all, especially as we asked for
any event during the patient's lifetime in the patient survey.
This sometimes very long time span may have led to a certain
underreporting of adverse reactions. However, we specifically
asked for severe adverse reactions which are usually
remembered well. Another limitation of the study design is
the fact that neither of the questionnaires has been validated.
Furthermore, we cannot exclude that some questions might
have been ambiguous for some participants. Finally, the
sample size of the patient survey was relatively small. Thus,
especially rare risks may not have been discovered in this
latter survey and the incidence rates reported have a large
confidence interval.
In order to gain further insight in severe adverse reactions
associated with exercise, new methods of reporting adverse
reactions need to be developed and established in order to identify
patients at risk. The data of our study, though, suggests that
exercise testing is safe in patients with CF when conducted under
controlled conditions by trained personnel. Although there are a
variety of possible adverse reactions in this population, the
incidence appears low for both in-hospital physical training and
physical activities and exercise during daily life.
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Appendix A
Survey 2005
1. institutional information
• private office, university hospital,
non-university hospital, rehabilitation hospital
• number of patients care for in 2005:
– Patients 18 years and older: _______________________
– Patients younger than 18 years: ___________________
2. complications during exercise testing
• Are you conducting exercise tests in your institution?
o yes o no
• If yes, how many patients underwent an exercise test in the
year 2005?
– Patients 18 years and older: _______________________
– Patients younger than 18 years: ___________________
Type of complication Number of patientsPneumothorax
Cardiac arrhythmia
Hypoglycaemia (symptomatic and measured)3. complications during in-hospital supervised training therapy
• Has your institution offered in-hospital supervised
training therapy during exercise- and physiotherapy
(endurance training, weight training)?
o yes o no
• If yes, how many patients took part in the training therapy
in the year 2005?
– Patients 18 years and older: _______________________
– Patients younger than 18 years: ___________________
Type of complication Number of patientsPneumothorax
Cardiac arrhythmia
Hypoglycaemia (symptomatic and measured)
Injuries (strains, contusions, fractures)Survey 2008
• Please enter your age: ______________________________
• Please check the box whether you're male or female:
o female o male
• Please enter your current FEV1 in%predicted:_____________
• Are you chronically colonized by Pseudomonas aeruginosa?
o yes o no
• How many hours per week do you engage in physical activity
and sports (e.g. soccer, running, dancing): __________h/week
• What kind of physical activity and sports did you participate in
during the last month?
o Activity / Sport 1:______________________________
o Activity / Sport 2:_____________________________o Activity / Sport 3:_____________________________
o Activity / Sport 4:_____________________________
o Activity / Sport 5:_____________________________
• Did you ever encounter severe adverse reactions during
physical exertion?
o No severe adverse reactions
o pneumothorax
o asthma attack (cough and shortness of breath occurring
after the end of exercise)
o unconsciousness
o injury
o any other problem:______________________________
• If applicable, please specify the symptoms and the situations of
the adverse reactions you reported: _____________________References
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